Workflow
Fulcrum Therapeutics(FULC) - 2024 Q4 - Annual Results

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2025 Fulcrum Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38978 47-4839948 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 26 Landsdowne Street Cambridge, Massachusetts 02139 (Address ...